USP7 and colonic neoplasm: To investigate the efficacy of USP7 as a potential target for cancer reversion in colon cancer organoids, we conducted USP7 knockdown experiments using the inhibitor P22077 in colon cancer organoids previously used in the process of network reconstruction.